Publicaciones en colaboración con investigadores/as de National Cancer Institute (9)

2021

  1. Minimal residual disease in Myeloma: Application for clinical care and new drug registration

    Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212

2016

  1. Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition

    Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 26-30

2014

  1. Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma

    Haematologica, Vol. 99, Núm. 7, pp. 1228-1235

2013

  1. Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival

    Molecular and Cellular Biology, Vol. 33, Núm. 22, pp. 4562-4578

2010

  1. Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection

    Cytometry Part B - Clinical Cytometry

  2. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL)

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1

  3. Prevalence of monoclonal B-cell lymphocytosis: A systematic review

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1

2008

  1. Flow cytometric immunophenotyping of cerebrospinal fluid

    Current Protocols in Cytometry

2007

  1. 2006 Bethesda international consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications

    Cytometry Part B - Clinical Cytometry